Podcast
Questions and Answers
Which factor most significantly differentiates the diagnostic approach to acute versus chronic hyperglycaemia?
Which factor most significantly differentiates the diagnostic approach to acute versus chronic hyperglycaemia?
- The primary method of glucose measurement (e.g., continuous glucose monitoring vs. HbA1c).
- The reliance on patient-reported symptoms rather than laboratory values for diagnosis of acute conditions.
- The immediate risk of life-threatening complications such as ketoacidosis or hyperosmolar hyperglycemic state in acute cases. (correct)
- The involvement of long-term microvascular and macrovascular complications in chronic cases.
How does chronic hyperglycaemia induce long-term cellular damage at the molecular level?
How does chronic hyperglycaemia induce long-term cellular damage at the molecular level?
- By increasing the activity of insulin receptors on cell surfaces, causing cells to become overly sensitive to insulin and disrupting metabolic pathways.
- By directly inhibiting insulin production in pancreatic beta cells, leading to a deficiency in glucose uptake.
- Via the accumulation of glycogen within cells, which disrupts osmotic balance and leads to cellular swelling and lysis.
- Through non-enzymatic glycation of proteins and lipids, forming advanced glycation end products (AGEs) that impair cellular function and promote inflammation. (correct)
In a patient presenting with symptoms suggestive of hyperglycaemia, which lab result would be most indicative of diabetic ketoacidosis (DKA)?
In a patient presenting with symptoms suggestive of hyperglycaemia, which lab result would be most indicative of diabetic ketoacidosis (DKA)?
- Elevated levels of high-density lipoprotein (HDL) cholesterol.
- Significantly elevated blood glucose levels with the presence of serum ketones. (correct)
- A low anion gap metabolic acidosis.
- An increased bicarbonate level on arterial blood gas analysis.
What is the physiological basis for the increased thirst (polydipsia) observed in individuals with uncontrolled hyperglycaemia?
What is the physiological basis for the increased thirst (polydipsia) observed in individuals with uncontrolled hyperglycaemia?
A non-diabetic patient's fasting blood glucose consistently measures between 5.5 and 6.9 mmol/L. According to current guidelines, how should this condition be interpreted and managed?
A non-diabetic patient's fasting blood glucose consistently measures between 5.5 and 6.9 mmol/L. According to current guidelines, how should this condition be interpreted and managed?
Following an oral glucose tolerance test (OGTT), a non-diabetic patient exhibits a 2-hour post-prandial glucose level of 6.0 mmol/L. Considering the NICE guidelines and the complex interplay of insulin sensitivity, glucose effectiveness, and hepatic glucose production, how should this result be interpreted?
Following an oral glucose tolerance test (OGTT), a non-diabetic patient exhibits a 2-hour post-prandial glucose level of 6.0 mmol/L. Considering the NICE guidelines and the complex interplay of insulin sensitivity, glucose effectiveness, and hepatic glucose production, how should this result be interpreted?
A researcher is investigating the impact of a novel therapeutic agent on glucose homeostasis in individuals with type 2 diabetes. The study involves measuring fasting blood glucose levels before and after the intervention. Considering the inherent biological variability and potential confounding factors, what statistical approach is most appropriate for accurately assessing the agent's efficacy in reducing fasting blood glucose?
A researcher is investigating the impact of a novel therapeutic agent on glucose homeostasis in individuals with type 2 diabetes. The study involves measuring fasting blood glucose levels before and after the intervention. Considering the inherent biological variability and potential confounding factors, what statistical approach is most appropriate for accurately assessing the agent's efficacy in reducing fasting blood glucose?
In a clinical trial evaluating the efficacy of a new insulin analog, researchers observe a statistically significant reduction in HbA1c levels but a concurrent increase in the frequency of nocturnal hypoglycemic episodes. Considering the complex interplay between glycemic control, patient safety, and quality of life, what is the most appropriate course of action?
In a clinical trial evaluating the efficacy of a new insulin analog, researchers observe a statistically significant reduction in HbA1c levels but a concurrent increase in the frequency of nocturnal hypoglycemic episodes. Considering the complex interplay between glycemic control, patient safety, and quality of life, what is the most appropriate course of action?
A patient with a history of poorly controlled type 1 diabetes presents with persistent hyperglycemia despite escalating insulin doses. Further investigation reveals elevated levels of circulating anti-insulin antibodies. Considering the complex interplay between insulin resistance, immune response, and glucose metabolism, what is the most appropriate therapeutic strategy?
A patient with a history of poorly controlled type 1 diabetes presents with persistent hyperglycemia despite escalating insulin doses. Further investigation reveals elevated levels of circulating anti-insulin antibodies. Considering the complex interplay between insulin resistance, immune response, and glucose metabolism, what is the most appropriate therapeutic strategy?
In a research setting, a novel glucose sensor demonstrates high accuracy and precision in vitro but exhibits significant signal drift and reduced sensitivity when implanted subcutaneously in vivo. Considering the complex interplay between sensor technology, tissue microenvironment, and biofouling, what strategies could be employed to improve the long-term performance and reliability of the glucose sensor in vivo?
In a research setting, a novel glucose sensor demonstrates high accuracy and precision in vitro but exhibits significant signal drift and reduced sensitivity when implanted subcutaneously in vivo. Considering the complex interplay between sensor technology, tissue microenvironment, and biofouling, what strategies could be employed to improve the long-term performance and reliability of the glucose sensor in vivo?
Flashcards
Fasting Glucose (Non-diabetic)
Fasting Glucose (Non-diabetic)
Normal fasting blood glucose range in non-diabetics.
Pre-meal Glucose (Non-diabetic)
Pre-meal Glucose (Non-diabetic)
Normal blood glucose range before meals in non-diabetics.
Postprandial Glucose
Postprandial Glucose
Blood glucose range 2 hours after a meal.
A1C Test
A1C Test
Signup and view all the flashcards
Target Fasting Glucose
Target Fasting Glucose
Signup and view all the flashcards
Blood Glucose Monitoring
Blood Glucose Monitoring
Signup and view all the flashcards
NICE Guidelines
NICE Guidelines
Signup and view all the flashcards
Fasting Blood Glucose
Fasting Blood Glucose
Signup and view all the flashcards
Pre-meal Glucose
Pre-meal Glucose
Signup and view all the flashcards
Study Notes
Normal Blood Glucose Ranges
- NICE guidelines give target blood glucose levels after meals. Non-diabetic range is less than 7.8 mmol/L.
Hyperglycemia Diagnostic Criteria
- OGTT preparation includes a 3-day unrestricted carbohydrate diet, overnight fasting for at least 8 hours, a 30-minute rest period, and remaining seated without smoking during the test.
- An OGTT sample occurs before and 2 hours after a 75g glucose drink.
Self-Monitoring Blood Glucose (SMBG)
- Self-Monitoring of Blood Glucose (SMBG) is recommended for those on multiple daily injections (MDI) of insulin or those using a continuous subcutaneous insulin infusion pump.
Acute Hyperglycemia
- Insulin deficiency effects protein metabolism by shifting toward protein catabolism.
- Muscle protein breakdown leads to muscle wasting, weakness, weight loss, and reduced growth in diabetic children.
- Reduced amino acid uptake and protein degradation results in excessive amino acids in the blood.
- Increased circulating amino acids can be used for gluconeogenesis, further aggravating hyperglycemia.
Hyperglycemia Symptoms
- Decreased glucose entry and increased glucose output causes symptoms like increased glucose in the urine (glycosuria).
- Hyperglycemia can cause fatigue.
Ketogenesis Overview
- Ketone bodies contain several different acids, such as acetoacetic acid. They are produced by the incomplete breakdown of fat during hepatic energy production. Therefore, ketosis leads to progressive metabolic acidosis.
- Acidosis can result in high urea and acidity in the blood.
Effects of Hyperglycemia
- Diabetic Ketoacidosis (DKA) often appears with polyuria, and polydipsia develop over a few hours.
- Individuals with DKA exhibit deep and laboured breathing, often with a fruity odour indicative of excess acetone.
- DKA may present with short history, and the most patients report abdominal pain
- DKA’s low pH due to acidosis leads to neurological dysfunction, which causes come and death
- Diabetic ketoacidosis (DKA) is defined by the degree of acidosis and level of consciousness/not the degree of hyperglycaemia or ketonaemia.
DKA Diagnosis
- The DKA Biochemical Triad can be determined by hyperketonaemia (≥ 3.0 mmol/L) or ketonuria (>2+ on standard urine sticks).
- Metabolic acidosis (venous bicarbonate is <15 mmol/L and/or venous pH is <7.3 (H+>50 nmol/L)) with an anion gap >10 mmol/L.
- Can be determined by observing the difference the primary measured and primary measured anions.
- Serum bicarbonate concentration in DKA can be usually moderately to markedly reduced.
- Additional losses of sodium and potassium is found after urinary excretion.
- When blood becomes acidic, hydrogen moves into cells (intracellular).
- The body will start to use potassium as a transfer, which will then be excreted.
- Initial blood potassium is typically normal or elevated, but there will be total body potassium depletion.
- The severity of diabetic ketoacidosis (DKA) is defined by the degree of acidosis and level of consciousness, not the degree of hyperglycaemia or ketonaemia.
DKA Treatment
- Even if plasma potassium is normal or raised, there is total body potassium depletion. Insulin administration and correction of hyperosmolality move potassium to the intracellular compartments with a risk of hypokalemia.
- Dextrose may be required to prevent hypoglycaemia.
DKA Management
- DKA requires early specialist involvement of groups such as young adults (18–25 years), and pregnant women.
- The goal of therapy is to correct acidaemia, restore circulatory volume, and normalize blood glucose and electrolyte imbalances.
- Upon resolution of DKA and once patients are eating and drinking normally, subcutaneous insulin is implemented as maintenance therapy.
Ketogenesis Overview
- Lipolysis releases large quantities of free fatty acids as and will cause reduced insulin.
- Severe hyperglycemia and high ketone concentrations cause osmotic diuresis causing volume lost.
Hyperosmolar Hyperglycemic State (T2DM)
- Hyperosmolar Hyperglycemic State is known as the non-ketotic hyperglycaemic coma because there is no build up of ketones.
Chronic Conditions
- Non-enzymatic Glycosylation (NEG) occurs as results in proteins and lipids that are glycated, called Advanced Glycation End-products.
- Blockage from chronic illnesses affects vessels.
- High glucose blood can also cause heart blindness and kidney problems
Diabeties Overview
- There are currently 422 million adults that live with diabetes, and 1.5 million yearly diease related complications.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
Explore the diagnosis and management of hyperglycaemia, focusing on differentiating acute and chronic conditions. Learn about long-term cellular damage at the molecular level and indicators of diabetic ketoacidosis. Understand the physiological reasons for increased thirst and the interpretation of non-diabetic fasting blood glucose levels.
